Johan Lantto

Title: Innovations and Contributions of Inventor Johan Lantto

Introduction

Johan Lantto is a notable inventor based in Lund, Sweden, recognized for his significant contributions to the field of biotechnology. With a total of nine patents to his name, Lantto has made strides in developing therapies that enhance immune responses, particularly in cancer treatment.

Latest Patents

Among his latest patents, Lantto has developed combination therapies targeting PD-1, TIM-3, and LAG-3. This disclosure relates to the use of antibodies specific for these targets in patients who require enhanced immunity. The therapies are particularly useful in treating diseases such as cancers. Another significant invention is related to anti-CD73 antibodies and compositions, which focus on methods for treating diseases and conditions associated with CD73 activity, including cancer.

Career Highlights

Throughout his career, Johan Lantto has worked with prominent companies in the biotechnology sector, including Symphogen A/S and Les Laboratoires Servier. His work has been instrumental in advancing therapeutic options for patients in need.

Collaborations

Lantto has collaborated with several professionals in his field, including Mikkel Wandahl Pedersen and Michael Kragh. These collaborations have contributed to the development of innovative therapies and have enhanced the impact of his work.

Conclusion

Johan Lantto's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of therapies aimed at improving patient outcomes in cancer treatment.